Podcast Episodes

Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier

Episode 279

We love to hear from our listeners. Send us a message.

On this week's episode of the Business of Biotech, Mardi Dier, CFO at Madrigal Pharmaceuticals…

2 months, 1 week ago

View Episode

Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.

Episode 278

We love to hear from our listeners. Send us a message.

On this week's episode of the Business of Biotech, we're speaking with Bernard Ravina, M.D., C…

2 months, 2 weeks ago

View Episode

BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals

Episode 277

We love to hear from our listeners. Send us a message.

On this week's episode — the last of our four-part series focused on South Florida — we catch …

2 months, 3 weeks ago

View Episode

BoB In South Florida: Anthony Japour, M.D., iTolerance

Episode 276

We love to hear from our listeners. Send us a message.

On this week's episode of the Business of Biotech -- part three in a four part series recorded…

2 months, 4 weeks ago

View Episode

BoB In South Florida: Daniel Teper, NAYA Therapeutics

Episode 275

We love to hear from our listeners. Send us a message.

In this week's episode of the Business of Biotech -- part two in a four-part series recorded i…

3 months ago

View Episode

BoB In South Florida: Raquel Cabo, Miami Biotech Collective

Episode 274

We love to hear from our listeners. Send us a message.

The Business of Biotech is on location in Miami this week! For the first episode in this four-…

3 months, 1 week ago

View Episode

The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott

Episode 273

We love to hear from our listeners. Send us a message.

On this week's episode of the Business of Biotech, Rob Abbott, CEO of ISPOR, explains how star…

3 months, 3 weeks ago

View Episode

Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham

Episode 272

We love to hear from our listeners. Send us a message.

On this week's episode, Joel Latham, President and CEO at Incannex Healthcare, talks about dev…

3 months, 4 weeks ago

View Episode

Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

Episode 271

We love to hear from our listeners. Send us a message.

On this week's episode, Lyle Small, Founder and CEO at Lahjavida, a dye drug conjugate start-u…

4 months ago

View Episode

Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.

Episode 270

We love to hear from our listeners. Send us a message.

On the Business of Biotech this week, Sahir Ali, Ph.D., founder and general partner at Modi Ve…

4 months, 1 week ago

View Episode